REFERENCES
- UNODC. World drug report, UNODC 2006. United Nations Publication, New York 2006
- Friedman H, Eisenstein T K. Neurological basis of drug dependence and its effects on the immune system. J Neuroimmunol 2004; 147(1–2)106–108
- Kosten T, Owens S M. Immunotherapy for the treatment of drug abuse. Pharmacol Ther 2005; 108(1)76–85
- Burtis C A, Edward R, Ashwood B. Tietz Fundementals of Clinical Chemistry. 5 ed. W B, Saunders Company, Philadelphia 2001
- Katzung B. Basic and Clinical Pharmacology. Lang Medical Books/McGraw-Hill, New York 2001
- Howard B, Hud A. Opioid analgesics. Goodman & Gilman's. The Pharmacological Basis of Therapeutics, 10th ed, J G Hardman, L E Limbird, A G Gilman. McGraw Hill, New York 2001
- Olsen G D. Morphine binding to human plasma proteins. Clin Pharmacol Ther 1975; 17(1)31–35
- Nagamatsu K, Ohno Y, Ikebuchi H, Takahashi A, Terao T, Takanaka A. Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. Biochem Pharmacol 1986; 35(20)3543–3548
- Gomez-Lechon M J, Ponsoda X, Jover R, Fabra R, Trullenque R, Castell J V. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes. Mol Toxicol 1987; 1(4)453–463
- Banerjee D, Sarkar N K. A study of hepatobiliary function in chronic heroin smokers. Addict Biol 1996; 1(2)197–200
- Ringle D A, Herndon B L. Immunologic effects of morphine administration in rabbits. J Immunol 1975; 115(3)876–883
- Walker M C, Simon E J. The purification of antimorphine antibodies by affinity chromatography. J Pharmacol Exp Ther 1977; 203(2)360–364
- Beranek J T, De Cato L, Adler F L. Binding of morphine by serum globulins from morphine-treated rabbits. I. Induction and measurement of binding. Int Arch Allergy Appl Immunol 1976; 51(3)298–310
- Li L, Zhao W Z, Yang S Q, Fu N, Xu J P. Preparation and characterization of antimorphine antiserum. Di Yi Jun Yi Da Xue Xue Bao. The second round name 2004; 24(6)673–676
- McCarthy L, Wetzel M, Sliker J K, Eisenstein T K, Rogers T J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 2001; 62(2)111–123
- Allolio B, Schulte H M, Deuss U, Kallabis D, Hamel E, Winkelman W. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol (Copenh) 1987; 114(4)509–514
- Roy S, Wang J, Gupta S, Charboneau R, Loh H H, Barke R A. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 2004; 147(1–2)78–81
- Rezaei Poor R ASAS, Nayarin H A. The effects of addiction on phagocytosis and cellular immunity. Journal of the Faculty of Paramedical Sciences 2003; 3(1)141–149
- Rezai Poor R EN, Salehi M, Nikbin B. Effects of addiction on humoral immunity. Journal of Medical Council of Islamic Rpublic of Iran 2003; 4(21)271–275
- Friedman H, Newton C, Klein T W. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16(2)209–219
- Bangsberg D R, Rosen J I, Aragon T, Campbell A, Weir L, Perdreau-Remington F. Clostridial myonecrosis cluster among injection drug users: A molecular epidemiology investigation. Arch Intern Med 2002; 162(5)517–522
- Battjes R J, Leukefeld C G, Pickens R W, Haverkos H W. The acquired immunodeficiency syndrome and intravenous drug abuse. Bull Narc 1988; 40(1)21–34
- Ramos V, Castro M A, de la Iglesia F, Martinez M M, Juega J, Sanchez P, et al. Immunoglobulins, beta-2 microglobulin and lymphocyte subpopulations in patients addicted to parenteral drugs (IVDA). An Med Interna 1992; 9(11)538–542